Team discovers new mechanism allowing tumor cells to escape immune surve

March 18, 2014

The immune system plays a pivotal role in targeting cancer cells for destruction. However, tumor cells are smart and have developed ways to avoid immune detection. A collaborative team of researchers at Moffitt Cancer Center recently discovered a novel mechanism that lung cancer cells use to block detection by a type of immune cell called a natural killer cell (NK cell).

NK cells find and destroy virally infected cells and also play an important role in detecting and killing tumor cells. However, tumors produce high amounts of a protein called Transforming Growth Factor-Beta (TGF-β) that suppresses the activity of NK cells.

A team of researchers led by Julie Y. Djeu, Ph.D., associate center director of education and training at Moffitt, discovered that TGF-β produced by tumor cells causes NK cells to make high levels of a molecule called microRNA-183 (miR-183). MicroRNAs are important regulators of gene expression. They bind to genetic components called RNA and target them for destruction. Scientists discovered in the early 2000s that deregulation of microRNAs can lead to the development of cancer.

Djeu's laboratory reported that miR-183 binds to the RNA for a protein called DAP12, resulting in significantly lower levels of DAP12 in NK cells. DAP12 plays a critical role in activating the NK cells' cytotoxic pathways; therefore, lower levels of DAP12 in NK cells results in a reduced ability to target .

The researchers confirmed their observations by studying tissue from lung cancer tumors. They discovered that in normal tissue NK cells had moderate to high levels of DAP12; however, the NK cells within or surrounding the tumor had significantly reduced levels of DAP12.

Djeu explained that, "The world of microRNAs is just being explored, especially within , to identify what they control. How microRNAs might intercept in cancer is unknown and we were able to provide insight into a critical means by which cancer cells exploit miR-183 to dampen ."

Lung cancer causes the most cancer-related deaths in the United States, and researchers are searching for new cellular targets to increase survival rates. Inhibiting TGF-β is not ideal because it is critical to normal cellular processes. However, the Moffitt scientists suggest that it may be possible to target the TGF-β-miR183-DAP12 pathway in patients with to activate the immune system and kill cancer cells.

Explore further: Fighting cancer with the immune system

More information: This study appeared online in Proceedings of the National Academy of Sciences on February 28.

Related Stories

Fighting cancer with the immune system

June 11, 2012

The human immune system has a natural ability to identify and attack tumor cells. Natural killer (NK) cells are innate immune cells that are particularly effective at killing tumor cells due to their ability to secrete cytotoxic ...

Cocktail boosts immune cells in fighting cancer

December 6, 2012

Natural killer cells, as part of the body´s immune system, can effectively fight cancer. Unfortunately, they quickly lose their aggressiveness and hence are unable to reject solid tumors. Scientists from the German Cancer ...

Cancer vaccine could use immune system to fight tumors

February 27, 2014

Cincinnati Cancer Center (CCC) and UC Cancer Institute researchers have found that a vaccine, targeting tumors that produce a certain protein and receptor responsible for communication between cells and the body's immune ...

Recommended for you

Ancient stress response provides clues to cancer resistance

April 25, 2017

Cancer is often able to craftily outwit the best techniques modern medicine has developed to treat it. In an attempt to understand and combat cancer's vaunted prowess, an unusual collaboration between physicists and a leading ...

Studying a catalyst for blood cancers

April 25, 2017

Imagine this scenario on a highway: A driver starts to make a sudden lane change but realizes his mistake and quickly veers back, too late. Other motorists have already reacted and, in some cases, collide. Meanwhile, the ...

Savior of T-cells may be enemy of liver immune cells

April 24, 2017

Researchers at Houston Methodist demonstrated that a surface protein called OX40, responsible for keeping one type of immune system cell alive, can trigger the death of liver immune cells, in turn starting a chain reaction ...


Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.